NCT04504331 2026-02-12Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast CancerStanford UniversityPhase 1 Terminated4 enrolled 11 charts
NCT02380209 2016-10-27An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast CancerUniversity of ArizonaPhase EARLY_PHASE1 Terminated8 enrolled